Kairos PharmaKAPA
13F holders, Q3 2024 (September 30)2holders
$1.54avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings. The largest holders were Virtu Financial LLC ($51K) and HRT Financial LP ($19K).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $70K |
| Exits | 0 | $0 |
Ownership 2 holders
| Virtu Financial LLC | 0.00% | New | 32,711 | $51K |
| HRT Financial LP | 0.00% | New | 12,609 | $19K |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.